600763 通策医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)7.85412.78714.04617.71127.940
总资产报酬率 ROA (%)5.2038.1918.92310.84717.528
投入资产回报率 ROIC (%)5.7959.29010.22312.53720.940

边际利润分析
销售毛利率 (%)40.75038.50238.53040.81446.057
营业利润率 (%)29.07924.31125.00926.99635.059
息税前利润/营业总收入 (%)30.44625.83326.64428.85835.876
净利润/营业总收入 (%)26.25619.90920.31922.64728.271

收益指标分析
经营活动净收益/利润总额(%)92.28892.96991.20493.42593.131
价值变动净收益/利润总额(%)6.4516.8948.4925.1905.760
营业外收支净额/利润总额(%)-0.303-0.666-0.4320.553-0.031

偿债能力分析
流动比率 (X)1.2791.6771.4032.3291.634
速动比率 (X)1.2291.6221.3672.2811.601
资产负债率 (%)27.50629.48831.83129.80436.536
带息债务/全部投入资本 (%)6.1146.9587.8173.8226.547
股东权益/带息债务 (%)1,219.7431,048.986924.8571,919.2771,039.440
股东权益/负债合计 (%)244.868220.944197.707215.512159.127
利息保障倍数 (X)20.92515.35115.29416.85343.336

营运能力分析
应收账款周转天数 (天)18.81518.07215.33211.8169.061
存货周转天数 (天)6.4065.5804.9074.8374.560